Literature DB >> 2421818

Antiviral treatment in chronic infection with hepatitis B virus.

G Alexander, R Williams.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2421818      PMCID: PMC1339848          DOI: 10.1136/bmj.292.6525.915

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  29 in total

1.  Comparative efficacy of adenine arabinoside 5' monophosphate and prednisone withdrawal followed by adenine arabinoside 5' monophosphate in the treatment of chronic active hepatitis type B.

Authors:  R P Perrillo; F G Regenstein; C J Bodicky; C R Campbell; G E Sanders; Y C Sunwoo
Journal:  Gastroenterology       Date:  1985-03       Impact factor: 22.682

2.  Treatment of chronic type B hepatitis with multiple ten-day courses of adenine arabinoside monophosphate.

Authors:  J H Hoofnagle; G L Davis; R G Hanson; S C Pappas; M G Peters; M I Avigan; J G Waggoner; R Howard; E A Jones; S E Straus
Journal:  J Med Virol       Date:  1985-02       Impact factor: 2.327

3.  Natural history of hepatitis-associated antigen-positive chronic liver disease.

Authors:  F J Dudley; P J Scheuer; S Sherlock
Journal:  Lancet       Date:  1972-12-30       Impact factor: 79.321

4.  Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen.

Authors:  C Bréchot; F Degos; C Lugassy; V Thiers; S Zafrani; D Franco; H Bismuth; C Trépo; J P Benhamou; J Wands
Journal:  N Engl J Med       Date:  1985-01-31       Impact factor: 91.245

5.  Fulminant hepatic failure in leukaemia and choriocarcinoma related to withdrawal of cytotoxic drug therapy.

Authors:  R M Galbraith; A L Eddleston; R Williams; A J Zuckerman
Journal:  Lancet       Date:  1975-09-20       Impact factor: 79.321

6.  Acute Dane particle suppression with recombinant leukocyte A interferon in chronic hepatitis B virus infection.

Authors:  C I Smith; J Weissberg; L Bernhardt; P B Gregory; W S Robinson; T C Merigan
Journal:  J Infect Dis       Date:  1983-11       Impact factor: 5.226

7.  Combination of short-term prednisolone and adenine arabinoside in the treatment of chronic hepatitis B. A controlled study.

Authors:  O Yokosuka; M Omata; F Imazeki; K Hirota; J Mori; K Uchiumi; Y Ito; K Okuda
Journal:  Gastroenterology       Date:  1985-08       Impact factor: 22.682

8.  Randomized controlled trial of adenine arabinoside monophosphate for chronic type B hepatitis.

Authors:  J H Hoofnagle; R G Hanson; G Y Minuk; S C Pappas; D F Schafer; G M Dusheiko; S E Straus; H Popper; E A Jones
Journal:  Gastroenterology       Date:  1984-01       Impact factor: 22.682

9.  In vitro alpha-interferon treatment of peripheral blood mononuclear cells improves interleukin-2 activity in HBV-related chronic liver disease.

Authors:  S Saxena; K T Nouri-Aria; M G Anderson; R Williams; A L Eddleston
Journal:  J Hepatol       Date:  1985       Impact factor: 25.083

10.  Diminished responsiveness of homosexual men to antiviral therapy for HBsAg-positive chronic liver disease.

Authors:  D M Novick; A S Lok; H C Thomas
Journal:  J Hepatol       Date:  1985       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.